<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05083741</url>
  </required_header>
  <id_info>
    <org_study_id>31454</org_study_id>
    <nct_id>NCT05083741</nct_id>
  </id_info>
  <brief_title>Comparison of Chitodex Gel vs NexFoam on Post-operative Outcomes in the Treatment of Chronic Rhinosinusitis</brief_title>
  <official_title>Head to Head Comparison of Chitodex Gel With Triamcinolone vs NexFoam With Triamcinalone on Post-operative Outcomes in the Treatment of Chronic Rhinosinusitis (CRS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Louis University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Louis University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the efficacy and outcomes of Chitodex gel plus&#xD;
      Kenalog versus Nexfoam plus Kenalog in patients with chronic rhinosinusitis (CRS) undergoing&#xD;
      sinus surgery. Both dressings are already known to be beneficial in controlling postoperative&#xD;
      bleeding and promote wound healing.&#xD;
&#xD;
      The trial will be single blinded randomized controlled trial and patients recruited will&#xD;
      undergo endoscopic sinus surgery as standard of care for treatment of CRS. Specific outcome&#xD;
      measures will be objective and subjective outcome scores post surgery as shown on attached&#xD;
      forms.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">August 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Patients eligible and consented to participate will be randomized towards the end of surgery (just before applying the nasal dressing) to determine which nostril will receive 10 mL of Chitodex gel plus Kenalog inserted into the middle meatus and which will receive NexFoam plus Kenalog.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Scores on Endoscopy</measure>
    <time_frame>12 (±2) weeks post surgery</time_frame>
    <description>Outcome measured based on the wound healing in the sinus openings made during surgery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptom Scores on Patients' Self-Directed Questionnaires</measure>
    <time_frame>12 (±2) weeks post surgery</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Chronic Rhinosinusitis</condition>
  <arm_group>
    <arm_group_label>Chitogel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Chitodex gel plus Kenalog inserted into the middle meatus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nexfoam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>NexFoam plus Kenalog inserted into the middle meatus</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Chitogel</intervention_name>
    <description>post-operative dressing within standard of care</description>
    <arm_group_label>Chitogel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nexfoam</intervention_name>
    <description>post-operative dressing within standard of care</description>
    <arm_group_label>Nexfoam</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Those who have had symptoms of chronic rhinosinusitis (nasal discharge, postnasal&#xD;
             drip, nasal obstruction, facial pain and pressure, lack of sense of smell) that has&#xD;
             been previously persistent for greater than 3 months AND&#xD;
&#xD;
          2. ≥ 18 years to ≤ 90 years AND&#xD;
&#xD;
          3. English speaking AND&#xD;
&#xD;
          4. are able to give written informed consent AND&#xD;
&#xD;
          5. are local and who will be returning to this center for postoperative follow-up care&#xD;
             AND&#xD;
&#xD;
          6. are indicated to undergo endoscopic sinus surgery and willing to return at 2-4, 6-8 &amp;&#xD;
             12 (± 2) weeks post-op.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. allergy to shellfish&#xD;
&#xD;
          2. pregnant or breastfeeding&#xD;
&#xD;
          3. Hepatitis or blood disorders&#xD;
&#xD;
          4. any drug allergy&#xD;
&#xD;
          5. allergy to potato starch (due to Nexfoam)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph D Brunworth, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Otolaryngology-Head &amp; Neck Surgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Otolaryngology Research Division</last_name>
    <phone>314-977-8884</phone>
    <email>oto-research@slu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Saint Louis University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63104</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Deniece D Webb, BA</last_name>
      <phone>314-977-4187</phone>
      <email>deniece.webb@health.slu.edu</email>
    </contact>
    <investigator>
      <last_name>Joseph D Brunworth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jastin L Antisdel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Ngoc Ha T, Valentine R, Moratti S, Robinson S, Hanton L, Wormald PJ. A blinded randomized controlled trial evaluating the efficacy of chitosan gel on ostial stenosis following endoscopic sinus surgery. Int Forum Allergy Rhinol. 2013 Jul;3(7):573-80. doi: 10.1002/alr.21136. Epub 2013 Jan 16.</citation>
    <PMID>23322408</PMID>
  </reference>
  <reference>
    <citation>Le T, Psaltis A, Tan LW, Wormald PJ. The efficacy of topical antibiofilm agents in a sheep model of rhinosinusitis. Am J Rhinol. 2008 Nov-Dec;22(6):560-7. doi: 10.2500/ajr.2008.22.3232.</citation>
    <PMID>19178792</PMID>
  </reference>
  <reference>
    <citation>Jervis-Bardy J, Boase S, Psaltis A, Foreman A, Wormald PJ. A randomized trial of mupirocin sinonasal rinses versus saline in surgically recalcitrant staphylococcal chronic rhinosinusitis. Laryngoscope. 2012 Oct;122(10):2148-53. doi: 10.1002/lary.23486. Epub 2012 Aug 2.</citation>
    <PMID>22865576</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 6, 2021</study_first_submitted>
  <study_first_submitted_qc>October 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2021</study_first_posted>
  <last_update_submitted>October 6, 2021</last_update_submitted>
  <last_update_submitted_qc>October 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Louis University</investigator_affiliation>
    <investigator_full_name>Joseph Brunworth, MD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

